LiMg_(0.1)Fe_(0.9)PO_4/C的合成与电化学性能研究

为了改善磷酸铁锂的电化学性能,以Li2CO3,FeC2O4.2H2O,(MgCO3)4.Mg(OH)2.5H2O,(NH4)2HPO4为原料,葡萄糖为碳源,用高温固相反应法合成了锂离子电池正极材料LiMg0.1Fe0.9PO4/C,用电化学方法测试了LiMg0.1Fe0.9PO4/C与LiFePO4/C的充放电性能和循环稳定性,利用X射线衍射、扫描电镜等表征了镁离子掺杂对磷酸铁锂结构和表面形貌的影响。实验结果表明:LiMg0.1Fe0.9PO4/C具有单一的橄榄石结构,且是由粒径为200~500 nm的颗粒组成,具有良好的电化学性能和循环稳定性能,镁离子的掺杂使磷酸铁锂具有更好的导电性,在0.1C下,10个循环后放电比容量为142.4 mA.h/g。     

Li4Ti5O12/Li1.3Al0.3Ti1.7(PO4)3复合负极材料的制备及其性能*

采用溶胶-凝胶法合成Li4Ti5O12/Li1.3Al0.3Ti1.7(PO4)3复合负极材料,通过X射线衍射、扫描电子显微镜、恒电流充放电、循环伏安和电化学阻抗研究复合材料的结构、形貌及电化学性能。结果表明：溶胶-凝胶法能合成纯相Li4Ti5O12/Li1.3Al0.3Ti1.7(PO4)3复合负极材料,所合成材料颗粒均匀。与纯相Li4Ti5O12相比,引入Li1.3Al0.3Ti1.7(PO4)3的Li4Ti5O12复合负极材料具有更低的锂离子嵌入/脱出阻抗,Li1.3Al0.3Ti1.7(PO4)3质量分数为1%、2%、3%、4%、5%的Li4Ti5O12复合材料首次放电容量比纯相Li4Ti5O12分别提高了6.2%、11.8%、15.5%、8.0%和2.0%。Li1.3Al0.3Ti1.7(PO4)3质量分数为3%的Li4Ti5O12复合负极材料20次循环后每次循环容量衰减率为0.022%,循环性能最好。     

废旧LiFePO_4正极材料的循环利用及电化学性能

以回收并经过除杂处理的废旧Li Fe PO4正极材料为原料,采用固相法补加不同摩尔分数的Li2CO3,在N2气氛中经焙烧修复补锂,获得再生的Li Fe PO4/C正极材料。结果表明,向废旧正极材料中补加摩尔分数为10%的Li2CO3可以有效弥补可循环锂的损失,再生后的正极材料有优异的倍率和循环性能。在0.1和20 C倍率下其放电比容量分别为157和73 m A·h/g,经200次循环后,容量几乎没有衰减。说明此方法可有效再生提高废旧Li Fe PO4正极材料的电化学性能,为大规模有效回收再利用废旧Li Fe PO4正极材料提供了一条可行的途径。     

锂离子电池正极材料LiFePO4的制备及电化学性能研究

以Li3PO4和Fe（3PO4）.28H2O为原料,采用固相法成功制备了锂离子电池正极材料LiFePO4,并讨论了Li3PO4用量对材料的影响。采用X射线衍射（XRD）、扫描电子显微镜（SEM）和充放电测试等手段对最终产物的物相、形貌和电化学性能进行了表征。结果表明,按计量比制备的LiFePO4样品具有较好的电化学性能,以0.1、0.5、1和5 C（1C=150 mA/g）的倍率进行充放电,首次放电比容量分别为135.6、123.8、116.2和56.5 mAh/g。磷酸锂过量8%制备的样品具有较好的高倍率性能,5C时放电比容量为80.3 mAh/g;而磷酸锂过量30%的样品则具有很好的小倍率放电比容量,0.1C时放电比容量为151.1 mAh/g。     

共生Li3PO4对LiFePO4电化学性能的影响

采用固相法制备出xLi3PO4/LiFePO4/C(x=0,0.025,0.05,0.10,0.15,0.20,0.50)复合锂离子电池阴极材料.电化学充放电测试显示,0.025Li3PO4/LiFePO4/C材料的性能优于同时制备的对比样品LiFePO4/C的.0.025Li3PO4/LiFePO4/C材料以0.1 ...     

LiFePO4/C正极材料的制备及性能表征

以LiH2PO4、Fe2O3及葡萄糖为原材料,采用高温高能球磨法(HTHEBM)制备了性能优良的碳包覆磷酸铁锂(LiFePO4/C)正极材料.在该法中,高能球磨将机械能转变为热能,有效降低了烧结温度且减少了烧结时间,在600℃下9 h烧结后获得纯相的LiFePO4/C正极材料.利用X射线衍射、扫描电镜、透射电镜、电化学...     

电池正极材料Li3V2-2x/3Mnx（PO4）3/C的制备及性能研究

以V2O5、NH4H2PO4、Li2CO3、(CH3COO)2Mn.4H2O原料,以葡萄糖和抗坏血酸为复合还原剂及碳源,通过常温还原-低温烧结法制备锂离子电池正极材料Li3V(2-2x/3)Mnx(PO4)3/C(x=0,0.03,0.06,0.09,0.12)。通过X射线衍射(XRD),扫描电镜(SEM),恒电流充放电测试对该正极材料的物相、结构、微观形貌以及电化学性能进行了表征。结果表明,Mn2+的掺杂对磷酸钒锂电化学性能的发挥影响很大,其中当锰掺杂量x=0.09时材料表现出最佳的电化学性能,0.2 C倍率条件下首次放电比容量131 mAh/g,循环50次后容量衰减仅为4.02%。     

锂离子电池正极材料Li3V2[(PO4)1-xFx]3/C的合成及性能表征

以LiH2PO4、LiF和V2O5为原料,蔗糖为还原剂,用碳热还原法合成了Li3V2[(PO4)1-xFx]3/C(x=0、0.02、0.05、0.08、0.10和0.15),并用X射线衍射、Fourier变换红外光谱、循环伏安、交流阻抗谱和恒流充放电技术研究了F-掺杂对材料结构和电化学性能的影响.结果表明:F-掺杂Li3V2(PO4)3/C与纯Li3V2(PO4)3/C均为单斜结构,但少量的F-掺杂可提高电极反应可逆程度和电导率,降低电荷传递阻抗;在所得的F-掺杂材料中,Li3V2[(PO4)0.95F0.05]3/C具有较好的电化学性能.在3.0～4.2V (vs.Li/Li+)循环时,电极的0.5C放电容量为124.4 mA·h/g,50次循环后容量保持率为98.5％,15C下的放电容量为84.7mA·h/g,50次循环后容量保持率为97.4％,而Li3V2(PO4)3/C的仅为59.2 mA·h/g和89.0％.     

磷酸铁锂电池高温循环性能影响研究

将Li Fe PO4/C锂离子电池分别在25℃(常温)、45℃、55℃下进行0%~100%DOD、1.0 C充/1.0 C放循环测试。结果显示,随温度的升高,电池的循环性能越差。本试验分别比较了电解液、负极材料对不同温度循环性能的影响。电解液中添加高沸点溶剂和抑制Li PF6分解的添加剂、负极使用小粒径中间相碳微球能够提高电池的高温循环性能。     

反应沉淀-焙烧法制备球形LiFePO4颗粒及其微结构表征

以FeSO4, H3PO4, LiOH和氨水为原料,采用反应沉淀-焙烧法制备了球形LiFePO4颗粒. 利用XRD和SEM对Fe3(PO4)2和Li3PO4、前驱体及其焙烧产物进行了表征;利用TG-DSC分析了Fe3(PO4)2和Li3PO4反应形成LiFePO4的过程. 结果表明,LiFePO4的形成过程及其微结构与两反应物的结构特征及其混合状态有关,制备的Fe3(PO4)2微球由片状或棒状微晶沿径向有序排列叠砌而成,内部呈辐射状构架,密度高、分散性和流动性好. 由球形Fe3(PO4)2和Li3PO4均匀混合的前驱体在700℃下于N2和H2气氛中焙烧3 h得到晶粒细小、无其他杂相、多孔的LiFePO4球形粉体,粒径为1~13 mm,粉体振实密度为1.25 g/cm3. 该粉体有望用作动力型绿色锂离子电池正极材料.     

磷酸铁锂改性制备工艺的研究

以柠檬酸作为分散剂,采用胶凝胶法制备锂离子电池正极材料磷酸铁锂,采用X射线衍射光谱法(XRD),扫描电子显微镜法(SEM)和电化学手段对目标材料进行了结构表征和性能测试。考察了碳改性过程中蔗糖加入量、后期煅烧时间及金属离子Zr4+掺杂改性对合成材料充放电性能的影响。结果表明,合成产物为橄榄石型磷酸亚铁锂,碳改性和Zr4+离子能有效控制颗粒长大,提升材料的电化学性能;加入60%蔗糖,掺杂锆离子,650℃烧结18 h制备的磷酸亚铁锂的可逆性好,0.2C放电比容量达到162 mAh·g-1。     

制备条件对磷酸铁锂电化学性能的影响

采用辅助微波加热的方法,制得了粒子较细、粒径分布窄的LiFePO4/C化合物。利用X射线衍射(XRD)、扫描电镜(SEM)和透射电镜(TEM)对所得样品的晶体结构、表面形貌和粒径分布进行了分析研究。试验表明,采用该反应方法有利于控制产物的形貌和粒径。用LiFePO4/C作正极材料进行了电池的充放电和循环伏安测试,结果显示,材料中锂离子的充放电平台相对锂电极电位为3.5 V左右,首次放电量为151 mA.h/g,表现出了良好的循环性能和高倍率性能。     

共沉淀法合成磷酸铁锂的途径概述

共沉淀法合成LiFePO4材料的步骤简单,成本低且颗粒均匀,通过控制材料的形貌,粒径,可制备出高振实密度,高倍率性能良好的材料。随着对共沉淀法的深入研究,合成的途径也越来越多,文章介绍了不同LiFePO4材料的合成途径和各种途径的优缺点,并对共沉淀法包覆和掺杂改性的研究情况做了简单的介绍。     

锂云母、锂瓷土中铁的测定

探讨锂云母、锂瓷土中铁的测定方法,用原子吸收光谱仪测定能得到满意的结果。     

橄榄石型磷酸铁锂的研究进展

介绍了橄榄石型磷酸锂铁（LiFePO4）的晶体结构,及共性能特点,评述了近年来各种制备LiFePO4的方法,包括固相反应法、水热合成法、液相共沉淀法以及其他多种方法。介绍了近年来对于提高LiFePO4的性能所进行的改性研究,并对其发展方向作了展望。     

Synthesis of sub-micrometer lithium iron phosphate particles for lithium ion battery by using supercritical hydrothermal method简

A supercritical hydrothermal method was employed to prepare sub-micrometer LiFePO4 particles with high purity and crystallinity. The structure and morphology of LiFePO4 particles were characterized by X-ray diffraction and scanning electron microscope. The electrochemical tests were carried out to determine the reversible capacity, rate and cycling performance of the LiFePO4 particles as cathode material for lithium ion battery. Experimental results show that solvent and calcining time have significant effects on purity, size and morphology of LiFePO4 particles. Mixed solvent contained deionized water and ethanol is conducive to synthesize smaller and more uniform particles. The size of LiFePO4 particles as-prepared is about 100-300 nm. The specific discharge capacities of the LiFePO4 particles are 151.3 and 128.0 mA. h. g-1 after first cycle at the rates of 0.1 and 1.0 C, respectively. It retains 95.0% of the initial capacity after 100 cycles at 1.0 C.     

锂离子电池正极材料磷酸铁锂行业研究

磷酸铁锂是一种锂离子电池的正极材料,本文介绍了磷酸铁锂的国内外市场需求、产品优势及改性研究目标,通过生产工艺路线优缺点对比及近年来磷酸铁锂价格变化趋势来确定磷酸铁锂今后研究方向,预测了磷酸铁锂发展前景以及行业发展趋势。     

Comparative Evaluation of Sucrosomial Iron and Iron Oxide Nanoparticles as Oral Supplements in Iron Deficiency Anemia in Piglets

Iron deficiency is the most common mammalian nutritional disorder. However, among mammalian species iron deficiency anemia (IDA), occurs regularly only in pigs. To cure IDA, piglets are routinely injected with high amounts of iron dextran (FeDex), which can lead to perturbations in iron homeostasis. Here, we evaluate the therapeutic efficacy of non-invasive supplementation with Sucrosomial iron (SI), a highly bioavailable iron supplement preventing IDA in humans and mice and various iron oxide nanoparticles (IONPs). Analysis of red blood cell indices and plasma iron parameters shows that not all iron preparations used in the study efficiently counteracted IDA comparable to FeDex-based supplementation. We found no signs of iron toxicity of any tested iron compounds, as evaluated based on the measurement of several toxicological markers that could indicate the occurrence of oxidative stress or inflammation. Neither SI nor IONPs increased hepcidin expression with alterations in ferroportin (FPN) protein level. Finally, the analysis of the piglet gut microbiota indicates the individual pattern of bacterial diversity across taxonomic levels, independent of the type of supplementation. In light of our results, SI but not IONPs used in the experiment emerges as a promising nutritional iron supplement, with a high potential to correct IDA in piglets.     

Iron Homeostasis in Health and Disease

Iron is required for the survival of most organisms, including bacteria, plants, and humans. Its homeostasis in mammals must be fine-tuned to avoid iron deficiency with a reduced oxygen transport and diminished activity of Fe-dependent enzymes, and also iron excess that may catalyze the formation of highly reactive hydroxyl radicals, oxidative stress, and programmed cell death. The advance in understanding the main players and mechanisms involved in iron regulation significantly improved since the discovery of genes responsible for hemochromatosis, the IRE/IRPs machinery, and the hepcidin-ferroportin axis. This review provides an update on the molecular mechanisms regulating cellular and systemic Fe homeostasis and their roles in pathophysiologic conditions that involve alterations of iron metabolism, and provides novel therapeutic strategies to prevent the deleterious effect of its deficiency/overload.     

Iron Homeostasis in the CNS: An Overview of the Pathological Consequences of Iron Metabolism Disruption

Iron homeostasis disruption has increasingly been implicated in various neurological disorders. In this review, we present an overview of our current understanding of iron metabolism in the central nervous system. We examine the consequences of both iron accumulation and deficiency in various disease contexts including neurodegenerative, neurodevelopmental, and neuropsychological disorders. The history of animal models of iron metabolism misregulation is also discussed followed by a comparison of three patients with a newly discovered neurodegenerative disorder caused by mutations in iron regulatory protein 2.